Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) General Information
Description
Intellectual property and exclusive global rights to develop and commercialise a carbonic anhydrase inhibitor located in Hamburg, Germany.
Contact Information
Corporate Office
- Hamburg
- Germany
Corporate Office
- Hamburg
- Germany
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) FAQs
-
Where is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) headquartered?
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is headquartered in Hamburg, Germany.
-
What industry is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) in?
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s primary industry is Buildings and Property.
-
Is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) a private or public company?
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is a Private company.
-
What is Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s current revenue?
The current revenue for Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) is .
-
Who are Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)’s investors?
Desitin Arzneimittel has invested in Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame).
-
When was Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) acquired?
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) was acquired on 23-Apr-2025.
-
Who acquired Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame)?
Desitin Arzneimittel (Global Rights to Patents Covering Sulthiame) was acquired by Apnimed.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process